Intrinsic Hepcidin IDx
Commercial- Indications
- Iron disorders
Company intelligence / Profile preview
Intrinsic LifeSciences pioneered the world’s first validated hepcidin ELISA assay and remains a leader in research-use-only diagnostic kits and CLIA-certified laboratory tests measuring key biomarkers of iron homeostasis. Their assays are widely used by academic researchers, pharmaceutical companies, and clinicians globally. While their core hepcidin test has not yet received FDA approval as an in vitro diagnostic device for routine clinical use, it has been validated in peer-reviewed studies and supports both research and patient management through their accredited laboratory.
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Intrinsic LifeSciences.